Matrix metalloproteinase-2 predicts cardiac mortality and heart failure hospitalization after acute myocardial infarction

被引：0
|
作者：
Yajima, K. [1 ]
Ohte, N. [2 ]
Tanaka, S. [1 ]
Kawamiya, T. [1 ]
Fujimaki, T. [1 ]
Kato, K. [1 ]
Hibino, T. [1 ]
Yokoi, K. [1 ]
Kimura, G. [2 ]
机构：
[1] Gifu Prefectural Tajimi Hosp, Tajimi, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [1] Matrix-metalloproteinase-2 predicts mortality and heart failure following myocardial infarction
    Ng, K.
    Dhillon, O.
    Kelly, D.
    Khan, S. Q.
    Quinn, P. A.
    Squire, I. B.
    Davies, J. E.
    Ng, L. L.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 : 393 - 393
  • [2] Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction
    Nakaya, R
    Uzui, H
    Shimizu, H
    Nakano, A
    Mitsuke, Y
    Yamazaki, T
    Ueda, T
    Lee, JD
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 105 (01) : 67 - 73
  • [3] Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure
    Ko, Dennis T.
    Khera, Rohan
    Lau, Geoffrey
    Qiu, Feng
    Wang, Yongfei
    Austin, Peter C.
    Koh, Maria
    Lin, Zhenqiu
    Lee, Douglas S.
    Wijeysundera, Harindra C.
    Krumholz, Harlan M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (07) : 736 - 746
  • [4] Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome
    Dhillon, Onkar S.
    Khan, Sohail Q.
    Narayan, Hafid K.
    Ng, Kelvin H.
    Mohammed, Noor
    Quinn, Paulene A.
    Squire, Iain B.
    Davies, Joan E.
    Ng, Leong L.
    [J]. CLINICAL SCIENCE, 2010, 118 (3-4) : 249 - 257
  • [5] Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction
    Wagner, DR
    Delagardelle, C
    Ernens, I
    Rouy, D
    Vaillant, M
    Beissel, J
    [J]. JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) : 66 - 72
  • [6] Development of matrix metalloproteinase-2 inhibitors against acute myocardial infarction
    Bencsik, P.
    Kupai, K.
    Gorbe, A.
    Varga, Z. V.
    Paloczi, J.
    Hajdu, I.
    Cseh, S.
    Dorman, G.
    Ferdinandy, P.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 109 : 49 - 50
  • [7] Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure
    Rumsfeld, JS
    Jones, PG
    Whooley, MA
    Sullivan, MD
    Pitt, B
    Weintraub, WS
    Spertus, JA
    [J]. AMERICAN HEART JOURNAL, 2005, 150 (05) : 961 - 967
  • [8] Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure
    Ferreira, Joao Pedro
    Santos, Mario
    Oliveira, Jose Carlos
    Marques, Irene
    Bettencourt, Paulo
    Carvalho, Henrique
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 104 (04) : 308 - 313
  • [9] Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-2 Affect Left Ventricular function after Acute Myocardial Infarction
    Yajima, K.
    Ohte, N.
    Yoshida, T.
    Oguri, M.
    Kato, K.
    Hibino, T.
    Yokoi, K.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 178 - 178
  • [10] A history of prior myocardial infarction was independently predictive of mortality but not of recurrent myocardial infarction or heart failure hospitalization in 5477 patients with acute myocardial infarction complicated by cardiac failure
    Willenheimer, R
    Gränsbo, K
    Snapinn, S
    Coats, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 153A - 153A
12345